Apple has released the iOS 18.4 update for all eligible iPhones and adds new Apple Intelligence features and more.
A POPULAR shopping centre will shut “indefinitely” as more than 30 store owners see their tenancies scrapped overnight. The ...
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported full-year 2024 financial ...
As of December 31, 2024, Fortress' consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as ...
A smattering of new features arrive across devices as Cupertino continues the slow and steady release of its flagship AI ...
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
Explore more
The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).
Following feedback to its July 2024 Call for Input (CfI) on placing greater reliance on the Consumer Duty instead of specific rules and guidance, ...
After a sluggish few years, hospital and health system dealmaking is gearing up for a resurgence in 2025 — driven by labor headwinds, tightening margins and the urgent need to modernize, according to ...
The new Logitech G Pro X TKL Rapid is a new standard for dedicated PC gamers, but it also succeeds for those looking for an ...
Only 7% of the FTSE 100 companies described skills and training as a strategic priority in their latest annual report.
NeOnc Technologies Holdings, Inc. (NASDAQ Global Market: NTHI), a clinical-stage medical biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results